Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1

Tekijä Wheeler, T.M., Krym, M.C., Thornton, C.A.
Julkaistu 2007

Signal transducer and activator of transcription-3 licenses Toll-like receptor 4-dependent interleukin (IL)-6 and IL-8 production via IL-6 receptor-positive feedback in endometrial...

Tekijä Cronin, J G, Kanamarlapudi, V, Thornton, C A, Sheldon, I M
Julkaisussa Mucosal Immunol (2016)

Health education in schools.

Tekijä Thornton, C A, Brennan, R K, Browne, A D, Denham, P C
Julkaistu 1978

Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR.

Tekijä Tian, B, White, R J, Xia, T, Welle, S, Turner, D H, Mathews, M B, Thornton, C A
Julkaistu 2000

Bioenergetic analysis of human peripheral blood mononuclear cells

Tekijä Jones, N, Piasecka, J, Bryant, A H, Jones, R H, Skibinski, D O F, Francis, Nigel J, Thornton, C A
Julkaisussa Clin Exp Immunol (2015)

Human gestation‐associated tissues express functional cytosolic nucleic acid sensing pattern recognition receptors

Tekijä Bryant, A. H., Menzies, G. E., Scott, L. M., Spencer‐Harty, S., Davies, L. B., Smith, R. A., Jones, R. H., Thornton, C. A.
Julkaisussa Clin Exp Immunol (2017)

Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1 [Image: see text]

Tekijä Logigian, E.L., Martens, W.B., Moxley, R.T., McDermott, M.P., Dilek, N., Wiegner, A.W., Pearson, A.T., Barbieri, C.A., Annis, C.L., Thornton, C.A., Moxley, R.T.
Julkaistu 2010

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

Tekijä Sorenson, E J., Windbank, A J., Mandrekar, J N., Bamlet, W R., Appel, S H., Armon, C, Barkhaus, P E., Bosch, P, Boylan, K, David, W S., Feldman, E, Glass, J, Gutmann, L, Katz, J, King, W, Luciano, C A., McCluskey, L F., Nash, S, Newman, D S., Pascuzzi, R M., Pioro, E, Sams, L J., Scelsa, S, Simpson, E P., Subramony, S H., Tiryaki, E, Thornton, C A.
Julkaistu 2008